New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2014
05:41 EDTAMAGAMAG Pharmaceuticals upgraded to Hold from Underperform at Jefferies
Jefferies upgraded AMAG Pharmaceuticals to Hold citing limited downside potential after the FDA issued a complete response letter for Feraheme broader use. The firm raised its price target for shares to $19 from $16.
News For AMAG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 18, 2015
06:55 EDTAMAGAMAG Pharmaceuticals price target raised to $85 from $60 at Leerink
Leerink raised its price target for AMAG Pharmaceuticals to $85 on expectations the 1mL vial formulation will help accelerate Makena's market share gain. The firm reiterates an Outperform rating on the stock.
May 12, 2015
07:52 EDTAMAGLeerink to hold a tour
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use